Evidence map›Paper›PMID 32083506›Full record

ArticleBioengineered2020

MicroRNA-145 overexpression inhibits neuroblastoma tumorigenesis

Jing Zhao, Kai Zhou, Liang Ma, Huanyu Zhang

Open access · goldAbstract read
In one paragraph

Article in Bioengineered, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 29 citations in OpenAlex.

  1. Epigenetic Dysregulation inInternational journal of molecular sciences · 2023
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Deciphering the Role of MicroRNAs in Neuroblastoma.Molecules (Basel, Switzerland) · 2021
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. MYCN in Neuroblastoma: "Old Wine into New Wineskins".Diseases (Basel, Switzerland) · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jing ZhaoDepartment of Pediatric Surgery, the Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Kai ZhouUrology, the Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Liang MaChild Health Division, the Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Huanyu ZhangDepartment of Pediatric Surgery, the Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.ORCID 0000-0002-3514-3699
Qingdao University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuroblastoma (NB) is responsible for 15% of all childhood cancer deaths. Despite advances in treatment and disease management, the overall 5-year survival rates remain poor in high-risk disease (25-40%). It is well known that miR-145 functions as a tumor suppressor in several types of cancer. However, the impact of miR-145 on NB is still ambiguous. Our aim was to investigate the potential tumor suppressive role and mechanisms of miR-145 in high-risk neuroblastoma. Expression levels of miR-145 in tissues and cells were determined using RT-qPCR. The effect of miR-145 on cell viability was evaluated using MTT assays, apoptosis levels were determined using TUNEL staining, and the MTDH protein expression was determined using western blot and RT-PCR. Luciferase reporter plasmids were constructed to confirm direct targeting for MTDH.

Indexed as

AdolescentApoptosisCell Line, TumorCell ProliferationCell SurvivalChildChild, PreschoolFemaleGene Expression Regulation, NeoplasticHumansImmunohistochemistryInfantInfant, NewbornMaleMicroRNAsNeuroblastomaMicroRNAsMIRN145 microRNA, humanapoptosismiR-145MTDHNeuroblastomatumorigenesis

Identifiers

PMID32083506
PMCPMC7039631
OpenAlexW3007093199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.